期刊文献+

临床分离产头孢菌素酶阴沟肠杆菌的耐药性研究 被引量:4

Study on the resistance of cephalosporin β-lactamase-producing Enterobacter cloacae
在线阅读 下载PDF
导出
摘要 目的:研究我院产头孢菌素酶(AmpC酶)阴沟肠杆菌的检出率、耐药情况及ampC基因型。方法:收集临床分离的耐药阴沟肠杆菌15株;三维试验检测AmpC酶;NCCLS方法检测超广谱β-内酰胺酶(ESBLs);琼脂二倍稀释法测定M IC值;PCR扩增检测ampC基因及序列测定。结果:15株菌中8株菌(53.3%)产AmpC酶,3株菌(20.0%)产ESBLs。产AmpC酶的菌株除对亚胺培南全敏感外,对其它抗菌药不同程度耐药。5株菌的ampC基因与阴沟肠杆菌ECLC074的ampC基因100%同源,3株菌与之99%同源,2株菌的AmpC酶发生了1个氨基酸残基的改变。结论:产AmpC酶是阴沟肠杆菌对β-内酰胺类抗生素耐药的主要机制之一。阴沟肠杆菌ECLC074 ampC基因是我院主要的阴沟肠杆菌ampC基因型。产AmpC酶的阴沟肠杆菌常呈多重耐药,亚胺培南是治疗此类菌所致感染的最有效药物。 Objective: To study the detection rate, the resistance phenotypes and the ampC gene of cephalosporin (AmpC) β-lactamase-producing Enterobacter cloacae isolates. Methods: 15 randomly chosen piperaeillin-resistant Enterobacter cloacae were isolated. AmpC β-lactamases were examined by three dimension test. Extended spectrum β-lactamases(ESBLs) were tested according to NCCLS Test. MICs of antibacterials were determined by two-fold agar dilution method, ampC genes were amplified by PCR and PCR products were sequenced. Results: Of 15 Enterobacter cloacae, 8 (53.3%) isolates produced AmpC β-lactamases and 3 (20.0%) produced ESBLs. AmpC β-lactamase-producing isolates were susceptive to imipenem, while they had the different resistant rates to the other antibacterials. Compared with Enterobacter cloacae ECLC074 ampC gene, the ampC genes of 5 strains had 100% homology, and those of the rest 3 strains had 99% homology. AmpC β-lactamases of 2 strains had one amino acid residue mutagenesis. Conclusion : Production of AmpC β-lactamases is one of the main resistant mechanisms of Enterebacter cloacae to β-lactam antibiotics. Enterobacter cloacae ECLC074 ampC gene is the main gene style of AmpC β-lactamases-producing Enterobacter cloacae. AmpC β-laetamase-producing Enterobacter cloacae isolates are muhidrug resistant frequently. Imipenem is the appropriate antibiotic for the treatment of the infections caused by this kind of strains.
出处 《四川生理科学杂志》 2005年第4期156-159,共4页 Sichuan Journal of Physiological Sciences
基金 四川省重点科技攻关项目(编号02SG022-030)
  • 相关文献

参考文献8

  • 1[1]Coudron PE,Moland ES,Thomson KS.Occurrence and detection of AmpC beta-lactamases among Escherichia coli,Klebsiella pneumoniae,and Proteus mirabilis isolates at a Veterans Medical Center.J Clin Microbio,2000; 38(5):1791 ~ 1796
  • 2[2]Haruta S,Nukaga M,Taniguchi K,et al.Resistance to oxyimino betalactams due to a mutation of chromosomal beta-lactamase in Citrobacter freundii.Microbiol Immunol,1998; 42 (3):165
  • 3[3]Levison ME,Mailapur YV,Pradhan SK,et al.Regional occurrence of plasmid-mediated SHV-7,an extended-spectrum beta-lactamase,in Enterobacter cloacae in Philadelphia teaching hospitals.Clin Infect Dis,2002; 35(12):1551 ~1554
  • 4[4]Bonnet R,Sampaio JL,Labia R,et al.A novel CTX-M beta-lactamase(CTX-M-8) in cefotaxime-resistant Enterobacteriaceae isolated in Brazil.Antimicrob Agents Chemother,2000; 44 (7):1936 ~19425 Medeiros AA.Evolution and dissemination of β-lactamases accelerated by generations of ? -lactam antibiotics.Clin Infect Dis,1997; 24:S19 ~S45
  • 5[6]Ghuysen JM.Serine β-lactamases and penicillin-binding proteins.Ann Rev Microbiol,1991; 45:37 ~67
  • 6[7]Raimondi A,Sisto F,Nikaido H.Mutation in Serratia marcescens AmpC β-Lactamase Producing High-Level Resistance to Ceftazidime and Cefpirome.Antimicrob Agents Chemother,2001; 45 (8):2331 ~ 2339
  • 7张永利,顾怡明,张杰,俞云松,周志慧,杜小玲.多重耐药阴沟肠杆菌β-内酰胺酶编码基因的研究[J].中华医院感染学杂志,2004,14(5):481-484. 被引量:19
  • 8陈晓玲,吕晓菊,范昕建,陈文昭,俞汝佳,高燕渝,蔡琰.101株阴沟肠杆菌的耐药性分析[J].中国抗生素杂志,2003,28(3):147-149. 被引量:18

二级参考文献18

  • 1[1]National Committee for Clinical Laboratory Standard. Performance standards for antimicrobial susceptibility testing [ S].Twelvth informational supplement. 2002,22: 90
  • 2[2]Liu Z G, Tan C, Chen M, et al. Analysis of Enterobacter cloacae infections and antimicrobial susceptibility [J]. Chin J Nosocomial, 2000,10 (6): 472
  • 3[3]Lei D P, Xü Y C, Xie X L. Drug resistance of 109 clinical isolates of Enterobacter cloacae [ J ]. Shanghai J Med Lab Sci, 1999,14(3): 147
  • 4[4]Kang M. Resistant mechanisms of Enterobacter cloacae of βlactams [J]. FMS Microbiol, 1997,20(3) :21
  • 5[5]Zhang Y L, Li J T, Zhao M W. Studies on chacacteristics of AmpC-type beta-lactamases of Enterobactercloacae [J]. Chin J Antibiot ,2000,20(6) :428
  • 6[6]Weigel L M, Steward C D, Tenover F C. gyrA mutations associated with fluoroquinolone resistance in eight species of Enterobacteriaceas [J]. AntimicrobAgents Chemother ,1998,42(10) :2661
  • 7[7]Linde H J, Notka F, Irtenkauf C, et al. Increase in MICs of ciprofloxacin in vivo in two closely related clinical isolates of Enterobacter cloacae [J ]. J Antimicrob Chemother, 2002,49(4) :625
  • 8Barnaud G, Labia R, Raskine L, et al. Extension of resistance to cefepime and cefpirome associated to a six amino acid deletion in the H-10 helix of the cephalosporinase of an Enterobacter cloacae clinical isolate[J]. FEMS Microbiol Lett, 2001, 195(2): 18
  • 9Levison ME, Mailapur YV, Pradhan SK, et al. Regional occurrence of plasmid-mediated SHV-7, an extended-spectrum beta-lactamase, in Enterobacter cloacae in Philadelphia teaching hospitals[J]. Clin Infect Dis, 2002, 35(12): 1551-1554.
  • 10Bonnet R, Sampaio JL, Labia R, et al. A novel CTX-M beta-lactamase (CTX-M-8) in cefotaxime-resistant Enterobacteriaceae isolated in Brazil[J]. Antimicrob Agents Chemother, 2000, 44(7): 1936-1942.

共引文献34

同被引文献23

引证文献4

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部